ENCePP web header
ENCePP web header

  • Ruthsarian
  • Home
  • Sitemap
  • Q & A
  • Notice Board
    • PhEpi & PhV activities
    • Research Funding
    • Conferences & meetings
    • Recruitment
  • Links
  • Contact Us

Links to Data sources

Sr. No Display Name Type Country Last Updated
1 EMBARC Data Source Transnational 04/04/2017

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Impact of EU label changes for hydroxyzine products: post-referral prescribing trends Professor Thomas MacDonald 04/03/2020
Finalised Impact of EU label changes for systemic diclofenac products: post-referral prescribing trends Professor Thomas MacDonald 16/02/2020
Finalised Cohort Study of the Relative Incidence of Major Cardiovascular Events Among Patients Initiating Prucalopride Versus a Matched Comparator Cohort Dr Alicia Gilsenan 10/08/2019
Ongoing Bendroflumethiazide versus Indapamide for Primary Hypertension: Observational (BISON) study within CPRD Professor Thomas MacDonald 13/03/2020
Planned Pregnancy outcomes in women exposed to oral cladribine: a multi-country cohort database study Dr Arana Alejandro 29/07/2020


  • News
  • About Us
  • ENCePP Documents
  • Training in PhEpi and PV

  • Code of Conduct
  • Standards & Guidances
  • ENCePP Study Seal
  • Public Consultation
  • Glossary of terms

  • Resources Database

  • Partners forum

  • EU PAS Register

  • About EU PAS Register

© 1995-2020 European Medicines Agency | Contact Us | Privacy Policy | Admin Login | Disclaimer

As of 1.2.2020, the UK is no longer an EU Member State. However, EU law still applies to the UK during the transition period.


combined emea eu logo European Medicines Agency Europa Website
Version: 4.4.1.1